Atomoxetine and methylphenidate treatment in children with ADHD: The efficacy, tolerability and effects on executive functions

Child Psychiatry and Human Development

Volumn 42, Issue 3, 2011, Pages 257-269

  Yildiz, Ozlem ^a   Sismanlar, Sahika G ^a   Memik, Nursu Cakin ^a   Karakaya, Isik ^a   Agaoglu, Belma ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Atomoxetine; Attention deficit hyperactivity disorder; Children; Executive functions; OROS MPH

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; PROPYLAMINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; PROPYLAMINES; TREATMENT OUTCOME;

EID: 79959724170     PISSN: 0009398X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10578-010-0212-3     Document Type: Article

References (30)

1. American Psychiatric Association (APA) (2000) Diagnostic and statistical manual of mental disorders, 4th edition-text revision (DSM-IV-TR). APA, Washington, DC
2. Biederman J, Spencer TJ (1999) Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242 (Pubitemid 30114440)
3. Safer DJ (2000) Commentary: stimulant treatment in the community. J Am Acad Child Adolesc Psychiatry 39:989-992
4. Popper CW (2000) Pharmacological alternatives to psychostimulants for the treatment of attention deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 9:605-646
5. Connor DF, Fletcher KE, Swanson JM (1999) A meta analysis of clonidine for symptoms of attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 38:1551-1560
6. Higgins ES (1999) A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder. J Fam Pract 48:15-20
7. Scahill L, Chappell PB, Kim YS, Katsovich L, Sheperd E et al (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067-1074 (Pubitemid 32623110)
8. Silver LB (1999) Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children. Pediatr Clin North Am 46:965-975
9. Wilens TE, Biederman J, Baldessarini RJ, Geller B, Schleifer D, Spencer TJ et al (1996) Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35:1491-1501 (Pubitemid 26360935)
10. Sauer JM, Ponsler GD, Mattiuz EL, Long AJ, Witcher JW, Thomasson HR et al (2003) Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism. Drug Metab Dispos 31:98-107 (Pubitemid 36735263)
11. Biederman J, Heiligenstein JH, Faries DE, Galil N, Dittmann R, Emslie GJ et al (2002) Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder. Pediatrics 110:e75
12. Michelson D, Faries DE, Wernicke J et al (2001) Atomoxetine in the treatment of children and adolescents with ADHD: a randomized, placebo-controlled dose-response study. Pediatrics 108:e83
13. Takahashi M, Takita Y, Yamazaki K et al (2009) A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmachol 19:341-350
14. Kemner JE, Starr HL, Ciccone PE, Hooper-Wood CG, Crockett RS (2005) Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. Adv Ther 22:498-512 (Pubitemid 43130867)
15. Kratochvil CJ, Heiligenstein J, Dittmann R, Spencer TJ, Biederman J, Wernicke J et al (2002) Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, openlabel trial. J Am Acad Child Adolesc Psychiatry 41:776-784 (Pubitemid 38338092)
16. Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ et al (2008) Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 165:721-730 (Pubitemid 351810541)
17. Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL et al (2005) A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. J Atten Disord 9:275-289 (Pubitemid 41551759)
18. Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65-94
19. Nigg JT (2005) Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry 57:1424-1435
20. Shallice T, Marzocchi GM, Coser S, Del Savio M, Meuter RF, Rumiah RI (2002) Executive function profile of children with attention deficit hyperactivity disorder. Dev Neuropsychol 21:43-71 (Pubitemid 34568632)
21. Kaufman J, Birmaher B, Brent D (1997) Schedule for affective disorders and schizophrenia for school age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988 (Pubitemid 27272932)
22. Guy E (1976) Assessment manual for psychopharmacology. National Institute of Mental Health, Rockville
23. Ercan ES, Amado S, Somer O (2001) Development of a test battery for attention deficit hyperactivity and disruptive behavior disorders. Cocuk ve Genclik Ruh Sagligi Dergisi 8:132-144
24. Wechsler D (1949) Manual of the wechsler intelligence scale for children. Psychological Corporation, San Antonio
25. Turgay A (1994) Disruptive behavior disorders child and adolescent screening and rating scales for children, adolescents, parents, and teachers. Integrative Therapy Institute Publication, West Blomfield
26. Heaton RK (1981) A manual for wisconsin card sorting test. Psychological Assessment Resources, Odessa FL
27. Karakas S (2004) BILNOT bataryasi El kitabi: Nöropsikiyatrik testler icin arastirma ve geli tirme cabalari. Hacettepe Üniversitesi Yayinlari, Ankara
28. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
29. Kilic BG, Kockar AY, Irak M, Sener S, Karakas S (2002) Stroop Testi TBAG Formunun 6-11 yas grubu cocuklarda standardizasyon calismasi. Cocuk ve Genclik Ruh Sagligi Dergisi 9(2):86-99
30. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C et al (2002) Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, Placebo-controlled study. Am J Psychiatry 159:1896-1901 (Pubitemid 35283256)